|
TGFBRAP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.565730E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.382800E-03 |
| Normal-vs-Stage2 |
5.003400E-01 |
| Normal-vs-Stage3 |
5.368800E-01 |
| Normal-vs-Stage4 |
3.434800E-01 |
| Stage1-vs-Stage2 |
3.532000E-01 |
| Stage1-vs-Stage3 |
2.379600E-01 |
| Stage1-vs-Stage4 |
9.165200E-01 |
| Stage2-vs-Stage3 |
9.286000E-01 |
| Stage2-vs-Stage4 |
6.235000E-01 |
| Stage3-vs-Stage4 |
5.677000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.523700E-03 |
| Normal-vs-AfricanAmerican |
1.349370E-01 |
| Normal-vs-Asian |
7.276100E-02 |
| Caucasian-vs-AfricanAmerican |
6.636000E-01 |
| Caucasian-vs-Asian |
7.843800E-01 |
| AfricanAmerican-vs-Asian |
6.821200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.031100E-04 |
| Normal-vs-Female |
4.086200E-01 |
| Male-vs-Female |
7.779900E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.916100E-02 |
| Normal-vs-Extreme_Weight |
3.29889999994837E-06 |
| Normal-vs-Obese |
7.171000E-01 |
| Normal-vs-Extreme_Obese |
1.723190E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.653200E-01 |
| Normal_Weight-vs-Obese |
1.209790E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.638200E-01 |
| Extreme_Weight-vs-Obese |
1.200410E-03 |
| Extreme_Weight-vs-Extreme_Obese |
5.922800E-01 |
| Obese-vs-Extreme_Obese |
2.665800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.000200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.997200E-01 |
| Normal-vs-Age(61-80Yrs) |
9.576800E-04 |
| Normal-vs-Age(81-100Yrs) |
9.67539999999767E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.149200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.679500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.425600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.718300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.283400E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.093000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.802750E-03 |
| Normal-VS-Type2 PRCC |
4.415900E-02 |
| Normal-VS-KIRP CIMP |
2.030000E-01 |
| Normal-VS-Unclassified PRCC |
5.235400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.359800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.059400E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.032400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.091700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.171700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.711800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.264100E-03 |
| Normal-vs-N1 |
7.732400E-01 |
| Normal-vs-N2 |
7.284600E-01 |
| N0-vs-N1 |
5.095600E-02 |
| N0-vs-N2 |
5.159400E-01 |
| N1-vs-N2 |
6.763200E-01 |
|
|
